Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Staccato Loxapine for Inhalation in Subjects on Chronic, Stable Antipsychotic Regimens

Next Previous
X
Search
Trial Profile

Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Staccato Loxapine for Inhalation in Subjects on Chronic, Stable Antipsychotic Regimens

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 17 Mar 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Loxapine (Primary)
  • Indications Schizophrenia
  • Focus Pharmacokinetics
  • Sponsors Alexza Pharmaceuticals

    • Most Recent Events

    • 27 May 2010 Results of this and another phase I loxapine safety trial (700043576) will be presented at the 163rd Annual Scientific Sessions of the American Psychiatric Association, according to an Alexza Pharmaceuticals media release.
    • 26 May 2010 Tolerability results, with respect to the incidence of cardiovascular adverse events, presented at the 163rd Annual Meeting of the American Psychiatric Association.
    • 08 Nov 2007 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top